Establishment Labs Holdings (ESTA) Capital Expenditures Growth (3y) (2020 - 2026)
Powered by 
Analysis
Establishment Labs Holdings (ESTA) Capital Expenditures Growth (3y) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.14 Bn | 177.54 Bn | 7.27 Bn | -0.66% |
| 2 | Intuitive Surgical | 125.03 Bn | 119.81 Bn | 1.96 Bn | -14.20% |
| 3 | Medtronic | 117.95 Bn | 109.13 Bn | 6.34 Bn | 12.42% |
| 4 | Stryker | 105.45 Bn | 101.97 Bn | 4.50 Bn | 9.94% |
| 5 | Boston Scientific | 66.16 Bn | 65.62 Bn | 3.85 Bn | 10.89% |
| 6 | Edwards Lifesciences | 49.54 Bn | 45.29 Bn | 1.35 Bn | 11.78% |
| 7 | Alcon | 33.69 Bn | 32.23 Bn | 1.68 Bn | 6.38% |
| 8 | Dexcom | 32.03 Bn | 30.08 Bn | 830.00 Mn | 12.81% |
| 9 | Steris | 21.01 Bn | 20.53 Bn | 684.20 Mn | 9.52% |
| 10 | Establishment Labs Holdings | 2.25 Bn | 2.18 Bn | 47.71 Mn | -14.51% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -14.51% |
| Mar 31, 2026 | -21.27% |
| Dec 31, 2025 | -41.65% |
| Sep 30, 2025 | -21.20% |
| Jun 30, 2025 | -49.24% |
| Mar 31, 2025 | -45.10% |
| Dec 31, 2024 | 40.86% |
| Sep 30, 2024 | 15.22% |
| Jun 30, 2024 | -3.93% |
| Mar 31, 2024 | 60.30% |
| Dec 31, 2023 | 367.59% |
| Sep 30, 2023 | 46.35% |
| Jun 30, 2023 | 113.34% |
| Mar 31, 2023 | 76.81% |
| Dec 31, 2022 | 139.89% |
| Sep 30, 2022 | 72.10% |
| Jun 30, 2022 | 43.78% |
| Mar 31, 2022 | 86.20% |
| Dec 31, 2021 | -26.16% |
| Sep 30, 2021 | 38.69% |